- Report
- September 2023
- 249 Pages
Global
From €4650EUR$5,380USD£3,950GBP
- Report
- April 2022
- 131 Pages
Global
From €1162EUR$1,299USD£1,022GBP
- Report
- June 2021
- 193 Pages
Global
From €4293EUR$4,799USD£3,775GBP
- Report
- August 2019
- 519 Pages
Global
From €4025EUR$4,499USD£3,539GBP
- Report
- October 2024
- 295 Pages
Global
From €1295EUR$1,498USD£1,100GBP
- Report
- April 2024
- 305 Pages
Global
From €5121EUR$5,925USD£4,350GBP
- Report
- December 2022
- 437 Pages
Global
From €4650EUR$5,380USD£3,950GBP
- Report
- June 2022
- 115 Pages
Global
From €1050EUR$1,257USD£955GBP
- Report
- May 2022
- 50 Pages
Global
From €500EUR$599USD£455GBP
- Report
- May 2022
- 32 Pages
Global
From €400EUR$479USD£364GBP
- Report
- October 2021
- 433 Pages
Global
From €2250EUR$2,694USD£2,047GBP
- Report
- November 2025
Global
From €750EUR$898USD£682GBP
- Report
- November 2025
Global
From €600EUR$718USD£546GBP
- Report
- November 2025
Global
From €450EUR$539USD£409GBP
- Report
- November 2025
Global
From €450EUR$539USD£409GBP
- Report
- November 2025
Global
From €300EUR$359USD£273GBP
- Report
- November 2025
Global
From €300EUR$359USD£273GBP
- Report
- August 2023
- 267 Pages
Global
From €2150EUR$2,574USD£1,956GBP
- Report
- February 2023
- 96 Pages
Global
From €1800EUR$2,155USD£1,638GBP
- Report
- July 2024
- 266 Pages
Global
From €4428EUR$4,950USD£3,893GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more